20 application-forms-"https:"-"https:"-"https:"-"IFM"-"IFM"-"IFM" positions at KINGS COLLEGE LONDON
Sort by
Refine Your Search
-
Category
-
Field
-
in the areas mentioned above, as well as the production of scientific publications and application showcases to drive research impact. The researcher will be expected to support impact creation
-
Development of Researchers, applies to Postdocs, Research Assistants, Research and Teaching Technicians, Teaching Fellows and AEP equivalent up to and including grade 7. Visit the Centre for Research Staff
-
Excellent IT skills including Microsoft Word, Excel, Outlook, OneNote, SharePoint, Forms and databases, Zoom/Teams and learning management systems such as Moodle Experience organising complex events to a
-
research and clinical practice. The post would be ideal for a clinician with an interest in the rapidly expanding field of immunopsychiatry. There is potential to develop a project for a PhD application for
-
. To find out how our managers will review your application, please take a look at our ‘How we Recruit ’ pages. Grade and Salary: £39,076 - £43,909 per annum, including London Weighting Allowance Job ID
-
About Us Founded in 1829, King’s College London is the 31st best university in the world and the 5th best in the UK. With an outstanding reputation for world-class teaching and cutting-edge research
-
About Us The School of Life Course & Population Sciences i s one of six Schools that make up the Faculty of Life Sciences & Medicine at King’s College London. The School unites over 400 experts in
-
application, please take a look at our ‘How we Recruit’ pages. Interviews are due to be held at Bush House, Strand Campus, on 4 March 2026. Grade and Salary: £65,091 - £74,613 per annum, including London
-
mark possible), research papers rated 4*, impact rated 4*, environment rated 4*(joint), Grade Point Average and Power. REF2021 rated as world-leading: 100% of our environment, 86% of our impact and 70
-
patients. This group has led on several large multicentre phase 3 and phase 4 clinical trials of biologic therapies in asthma as well as real world studies of biologic therapies in EGPA. The applicant